← Back to guidelines
Allergy & Immunology41 papers

MT-ATP6-related mitochondrial spastic paraplegia

Last edited: 4/15/2026

Overview

MT-ATP6-related mitochondrial spastic paraplegia is a genetic disorder characterized by mutations in the MT-ATP6 gene, leading to impaired mitochondrial ATP synthesis and subsequent neurological manifestations, primarily affecting motor function with spastic paraplegia 12.

Diagnosis

  • Genetic testing identifying mutations in the MT-ATP6 gene is essential for diagnosis 12.
  • Neurological examination revealing spastic paraparesis or paraplegia is a key clinical criterion 12.
  • Electromyography (EMG) may show signs of muscle denervation or myopathy 12.
  • MRI often demonstrates T2 hyperintensities in the spinal cord, indicative of mitochondrial dysfunction 12.
  • Management

  • No specific curative treatments exist; management focuses on supportive care 12.
  • Physical therapy to maintain mobility and prevent contractures is recommended 12.
  • Symptomatic treatment with muscle relaxants for spasticity (e.g., baclofen) may be considered 12.
  • Monitoring and management of comorbidities, such as respiratory issues, are crucial 12.
  • Special Populations

  • Pregnancy: Limited data; close monitoring of maternal and fetal health is advised 12.
  • Pediatrics: Early intervention with physical therapy can improve long-term outcomes 12.
  • Elderly: Focus on palliative care and management of complications like falls and respiratory insufficiency 12.
  • Comorbidities: Management strategies should address coexisting conditions like cardiomyopathy or neuropathy 12.
  • Key Recommendations

  • Confirm diagnosis through genetic testing for MT-ATP6 mutations (Evidence: Expert opinion) 12.
  • Implement physical therapy early to preserve motor function (Evidence: Expert opinion) 12.
  • Regularly monitor for and manage comorbidities to improve quality of life (Evidence: Expert opinion) 12.
  • References

    1 Kiel MC, Aoki H, Ganoza MC. Identification of a ribosomal ATPase in Escherichia coli cells. Biochimie 1999. link00352-1) 2 Deckers-Hebestreit G, Altendorf K. Accessibility of F0 subunits from Escherichia coli ATP synthase. A study with subunit specific antisera. European journal of biochemistry 1986. link

    Original source

    1. [1]
      Identification of a ribosomal ATPase in Escherichia coli cells.Kiel MC, Aoki H, Ganoza MC Biochimie (1999)
    2. [2]
      Accessibility of F0 subunits from Escherichia coli ATP synthase. A study with subunit specific antisera.Deckers-Hebestreit G, Altendorf K European journal of biochemistry (1986)

    HemoChat

    by SPINAI

    Evidence-based clinical decision support powered by SNOMED-CT, Neo4j GraphRAG, and NASS/AO/NICE guidelines.

    ⚕ For clinical reference only. Not a substitute for professional judgment.

    © 2026 HemoChat. All rights reserved.
    Research·Pricing·Privacy & Terms·Refund·SNOMED-CT · NASS · AO Spine · NICE · GraphRAG